These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9204997)

  • 21. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
    Noonan KE; Beck C; Holzmayer TA; Chin JE; Wunder JS; Andrulis IL; Gazdar AF; Willman CL; Griffith B; Von Hoff DD; Roninson IB
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7160-4. PubMed ID: 1976252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells.
    Wang X; Ji C; Ma D; Zhao J; Hou M; Yu H; Zang S
    Leuk Lymphoma; 2007 Aug; 48(8):1600-9. PubMed ID: 17701592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug-resistant gene expression in small-cell lung cancer.
    Savaraj N; Wu CJ; Xu R; Lampidis T; Lai S; Donnelly E; Solomon J; Feun LG
    Am J Clin Oncol; 1997 Aug; 20(4):398-403. PubMed ID: 9256898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo.
    Shen LZ; Hua YB; Yu XM; Xu Q; Chen T; Wang JH; Wu WX
    World J Gastroenterol; 2005 Feb; 11(7):1060-4. PubMed ID: 15742416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy.
    Gruber A; Areström I; Albertioni F; Björkholm M; Peterson C; Vitols S
    Leuk Lymphoma; 1995 Aug; 18(5-6):435-42. PubMed ID: 8528050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quantitative analysis of multidrug resistance phenotype in hematological malignancies].
    Kobayashi H; Takemura Y
    Rinsho Byori; 1998 Apr; 46(4):380-90. PubMed ID: 9594630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperthermia for treatment of rectal cancer: evaluation for induction of multidrug resistance gene (mdr1) expression.
    Stein U; Rau B; Wust P; Walther W; Schlag PM
    Int J Cancer; 1999 Jan; 80(1):5-12. PubMed ID: 9935221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells.
    Daschner PJ; Ciolino HP; Plouzek CA; Yeh GC
    Breast Cancer Res Treat; 1999 Feb; 53(3):229-40. PubMed ID: 10369069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias.
    Beck J; Niethammer D; Gekeler V
    Cancer Lett; 1994 Oct; 86(1):135-42. PubMed ID: 7954350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A diagnostic tool for monitoring multidrug resistance expression in human tumor tissues.
    Schwarzenbach H
    Anal Biochem; 2002 Sep; 308(1):26-33. PubMed ID: 12234460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDR1/P-GP expression as a prognostic factor in acute leukemias.
    Marie JP; Legrand O
    Adv Exp Med Biol; 1999; 457():1-9. PubMed ID: 10500774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug resistance in acute leukemia: a comparison of different diagnostic methods.
    Pall G; Spitaler M; Hofmann J; Thaler J; Ludescher C
    Leukemia; 1997 Jul; 11(7):1067-72. PubMed ID: 9204993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes.
    Tanaka S; Kamitani H; Amin MR; Watanabe T; Oka H; Fujii K; Nagashima T; Hori T
    J Neurooncol; 2000; 46(2):157-71. PubMed ID: 10894369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
    Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
    World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance.
    Andrews DW; Das R; Kim S; Zhang J; Curtis M
    Neurosurgery; 1997 Jun; 40(6):1323-32; discussion 1333-4. PubMed ID: 9179912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
    J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonradioactive quantification of mdr1 mRNA by polymerase chain reaction amplification coupled with HPLC.
    van Hille B; Lohri A; Reuter J; Herrmann R
    Clin Chem; 1995 Aug; 41(8 Pt 1):1087-93. PubMed ID: 7543032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of PGY1/MDR1 mRNA level in human KB cells by antisense oligonucleotide conjugates. RNA accessibility in vitro and intracellular antisense activity.
    Kostenko EV; Laktionov PP; Vlassov VV; Zenkova MA
    Biochim Biophys Acta; 2002 Jun; 1576(1-2):143-7. PubMed ID: 12031494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug resistance in oncology: diagnostic and therapeutic approaches.
    Robert J
    Eur J Clin Invest; 1999 Jun; 29(6):536-45. PubMed ID: 10354216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.